Real-time enrollment status for this inflammatory bowel disease (ibd) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:01 PM UTC
| NCT Number | NCT07368972 |
| Recruiting Status | Recruiting |
| Condition | Inflammatory Bowel Disease (IBD) |
| Phase | PHASE2 |
| Target Enrollment | 21 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Disc Medicine, Inc |
| Last Updated on CT.gov | September 23, 2026 (2 weeks ago) |
As of October 12, 2026: Clinical trial NCT07368972 is currently recruiting participants. This phase2 study for inflammatory bowel disease (ibd) is actively seeking new participants at 15 locations across the United States. The study is sponsored by Disc Medicine, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07368972 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07368972 was last updated 2 weeks ago (September 23, 2026). HelloStudys verifies this status automatically.